A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion

Background. Proper diagnosis of pancreatic lesion etiology is a challenging clinical dilemma. Studies suggest that surgery for suspected pancreatic ductal adenocarcinoma (PDAC) reveals a benign lesion in 5% to 13% of cases. The aim of our study was to assess whether routinely used biomarkers such as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dis Markers
Main Authors: Hogendorf, Piotr, Skulimowski, Aleksander, Durczyński, Adam, Kumor, Anna, Poznańska, Grażyna, Oleśna, Aleksandra, Rut, Joanna, Strzelczyk, Janusz
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5357521/
https://ncbi.nlm.nih.gov/pubmed/28356610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8629712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados